India’s competition regulator, the Competition Commission of India (CCI), clears Advent International’s proposed ₹3,150 crore investment in Yatharth Hospitals. The decision removes a key regulatory hurdle for the transaction, enabling the deal to move forward.
Across the two reports, the transaction is described as growth-focused capital for Yatharth Hospitals. Both outlets say the funding is intended to support the hospital chain’s expansion and strengthen its healthcare presence, though they highlight slightly different emphasis: one notes Advent’s ability to expand its footprint in India’s fast-growing hospital and healthcare services market, while the other frames the outcome primarily as regulatory clearance facilitating expansion plans.
